 |
Shift Bioscience
Last updated: September 26, 2025
Daniel Ives, CEO and Founder
UK | Funding: £12.5M (+)
Website: http://shiftbioscience.com
Shift Bioscience is creating new drug targets and diagnostic tools to enhance healthy lifespan through the repair of mitochondrial genes that cause neurodegenerative diseases or coronary heart disease.
Website: http://shiftbioscience.com
Shift Bioscience is creating new drug targets and diagnostic tools to enhance healthy lifespan through the repair of mitochondrial genes that cause neurodegenerative diseases or coronary heart disease.
